In summary, our study has shown the potential of the docetaxel+lovastatin combination for the efficient induction of human gastric cancer cell death, among other tumour types, and the ability of lovastatin to trigger apoptosis of cancer cells overexpressing the MDR-1 gene. This evidence concerns the gene ABCB1 and neoplasm.